HONG KONG, Sep 10, 2021 - (ACN Newswire) - Recently, Berry Oncology, a company focusing on genomic testing of cancers in China, announced the completion of a US$99.15 million Series B1 financing round, with Legend Capital's continuous support. This B1 financing round was led by China Merchants Capital Management Co., Ltd. Existing investors...